Apricoxib

Apricoxib
Apricoxib structure.svg
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
Chemical and physical data
Formula C19H20N2O3S
Molar mass 356.4387 g/mol g·mol−1
3D model (JSmol)

Apricoxib is an experimental anticancer drug. It is a COX-2 inhibitor which is intended to improve standard therapy response in molecularly defined models of pancreatic cancer.[1] Development was abandoned in 2015 due to poor clinical trial results.[2]

See also[edit]

References[edit]